Literature DB >> 23902490

Access to patient-level data from GlaxoSmithKline clinical trials.

Perry Nisen1, Frank Rockhold.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23902490     DOI： 10.1056/NEJMsr1302541

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  43 in total

1.  The project data sphere initiative: accelerating cancer research by sharing data.

Authors:  Angela K Green; Katherine E Reeder-Hayes; Robert W Corty; Ethan Basch; Mathew I Milowsky; Stacie B Dusetzina; Antonia V Bennett; William A Wood
Journal:  Oncologist       Date:  2015-04-15

Review 2.  Precision medicine in chronic disease management: The multiple sclerosis BioScreen.

Authors:  Pierre-Antoine Gourraud; Roland G Henry; Bruce A C Cree; Jason C Crane; Antoine Lizee; Marram P Olson; Adam V Santaniello; Esha Datta; Alyssa H Zhu; Carolyn J Bevan; Jeffrey M Gelfand; Jennifer S Graves; Douglas S Goodin; Ari J Green; H-Christian von Büdingen; Emmanuelle Waubant; Scott S Zamvil; Elizabeth Crabtree-Hartman; Sarah Nelson; Sergio E Baranzini; Stephen L Hauser
Journal:  Ann Neurol       Date:  2014-10-14       Impact factor: 10.422

3.  Background rates of disease in Latin American children from a rotavirus vaccine study.

Authors:  Marc Baay; Kaatje Bollaerts; Claudio Struchiner; Thomas Verstraeten
Journal:  Hum Vaccin Immunother       Date:  2017-04-25       Impact factor: 3.452

4.  Open access medical publications.

Authors:  Lawrence Grouse
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

Review 5.  Regulating prescription drugs for patient safety: does Bill C-17 go far enough?

Authors:  Matthew Herder; Elaine Gibson; Janice Graham; Joel Lexchin; Barbara Mintzes
Journal:  CMAJ       Date:  2014-03-10       Impact factor: 8.262

6.  Time to ensure that clinical trial appropriate results are actually published.

Authors:  Rafael Dal-Ré; Arthur L Caplan
Journal:  Eur J Clin Pharmacol       Date:  2014-01-11       Impact factor: 2.953

7.  Increasing value and reducing waste: addressing inaccessible research.

Authors:  An-Wen Chan; Fujian Song; Andrew Vickers; Tom Jefferson; Kay Dickersin; Peter C Gøtzsche; Harlan M Krumholz; Davina Ghersi; H Bart van der Worp
Journal:  Lancet       Date:  2014-01-08       Impact factor: 79.321

8.  Availability and Use of Shared Data From Cardiometabolic Clinical Trials.

Authors:  Muthiah Vaduganathan; Amulya Nagarur; Arman Qamar; Ravi B Patel; Ann Marie Navar; Eric D Peterson; Deepak L Bhatt; Gregg C Fonarow; Clyde W Yancy; Javed Butler
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

9.  DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS.

Authors:  Nophar Geifman; Atul J Butte
Journal:  Pac Symp Biocomput       Date:  2016

10.  Sea change in open science and data sharing: leadership by industry.

Authors:  Harlan M Krumholz; Cary P Gross; Katrina L Blount; Jessica D Ritchie; Beth Hodshon; Richard Lehman; Joseph S Ross
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.